2025-09-23 - Analysis Report
Okay, here's an analysis of XRP-USD based on the provided data, formatted for a report.

**XRP-USD Stock Analysis**

**1. Executive Summary**

XRP-USD is a cryptocurrency.

**2. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** XRP-USD
*   **Cumulative Return (XRP-USD):** 610.12%
*   **Cumulative Return (VOO):** 85.56%
*   **Absolute Divergence (XRP-USD - VOO):** 536.5
*   **Divergence Range (Max: 950.8, Min: -59.2)**
*   **Relative Divergence:** 59.0 (Indicates XRP-USD's outperformance is in the upper-mid range of its historical divergence from VOO.)

**Analysis:** XRP-USD has significantly outperformed the S&P 500 (VOO) over the analyzed period. However, the relative divergence of 59.0 indicates that while the outperformance is substantial, it's not at the extreme upper end of its historical range.

**3. Alpha and Beta Analysis**

| Year       | CAGR     | MDD   | Alpha    | Beta  | Cap(B) |
| ---------- | -------- | ----- | -------- | ----- | ------ |
| 2017-2019  | -44.0%   | 67.2% | -59.0%   | 0.0   | 11.0   |
| 2018-2020  | -301.0%  | 67.2% | -320.0%  | -0.0  | 12.6   |
| 2019-2021  | 215.0%   | 73.3% | 166.0%   | 0.0   | 47.5   |
| 2020-2022  | 68.0%    | 74.9% | 65.0%    | -0.0  | 19.4   |
| 2021-2023  | 93.0%    | 74.9% | 75.0%    | 0.4   | 35.1   |
| 2022-2024  | 614.0%   | 75.4% | 589.0%   | 0.3   | 118.8  |
| 2023-2025  | 538.0%   | 75.4% | 480.0%   | 0.3   | 170.8  |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows significant volatility over different periods, ranging from highly negative to very high positive values.  This highlights the high-risk, high-reward nature of XRP-USD.
*   **MDD:**  Maximum Drawdown is consistently high, indicating significant potential for losses during market downturns.
*   **Alpha:**  The Alpha values are predominantly positive and very large, suggesting XRP-USD's performance is largely independent of the market. The negative Alpha in some periods indicate underperformance relative to the benchmark, but the magnitude of the positive Alpha values in other periods outweigh these.
*   **Beta:** Beta is low, suggesting a weak correlation with the S&P 500.
*   **Cap:** Market Cap is on the rise.

**4. Recent Price Action**

*   **Current Price:** 2.99
*   **Last Market Data:**
    *   **Price:** 2.86
    *   **Previous Close:** 2.85
    *   **Change:** 0.16 (Slight positive movement)
*   **Moving Averages:**
    *   **5-day MA:** 3.03
    *   **20-day MA:** 2.95
    *   **60-day MA:** 3.05

**Analysis:**

*   The current price is slightly above the 20-day moving average but below both the 5-day and 60-day moving averages. This mixed signal suggests potential consolidation or indecision in the short term.
*   The small positive change in the last market data indicates a very slight upward trend.

**5. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.34 (Low Risk)
*   **RSI:** 59.08 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.37 (Slightly positive - indicating a potential upward trend)
*   **Hybrid Signal:** Buy 90% of cash (2 shares - Safe - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** -1.8 (Short-term decline in relative divergence)
*   **Expected Return (%):** 131.4 (Long-term expected outperformance vs. S&P 500 if dollar cost averaged)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is in a neutral zone, suggesting no strong momentum in either direction.
*   The PPO is slightly positive.
*   The hybrid signal recommends buying, suggesting a positive outlook despite the recent decline in relative divergence.
*   The negative delta in relative divergence indicates a short-term drop in the performance relative to the S&P 500, suggesting some underperformance recently.
* The high expected return is noteworthy but should be viewed with caution considering the historical volatility.

**6. Recent News & Significant Events**

*   **[2025-09-23] /C O R R E C T I O N -- BillionToOne/:** A correction notice is generally neutral but could indicate minor prior inaccuracies.
*   **[2025-09-23] Microvast at BICES 2025: Electrifying Construction Machinery:**  This is irrelevant as it is not related to XRP-USD.
*   **[2025-09-23] Only 1% of Pharma Research Goes to Women's Health. Melinda French Gates Is Investing $100M to Change That.:**  This is irrelevant as it is not related to XRP-USD.
*   **[2025-09-23] Trump to meet with Democrats as shutdown inches closer:**  General market news that could indirectly impact all assets.
*   **[2025-09-23] KOCCA to Host KOREA GAME ROADSHOW at TOKYO GAME SHOW 2025:**  This is irrelevant as it is not related to XRP-USD.
*   **[2025-09-23] With Millions of Children's Lives on the Line, Bill Gates Says Humanity Is at a Crossroads:**  General societal/philanthropic news, unlikely to directly impact XRP-USD.

**Analysis:**

The news items are a mixed bag. The correction notice is neutral. The political news regarding a potential government shutdown could induce market volatility generally. The other news items are irrelevant to the analysis.

**7. Analyst Opinions**

*   **Analyst Consensus:** Not provided.

**8. Overall Conclusion**

XRP-USD exhibits high volatility and significant outperformance compared to the S&P 500, but also carries a high risk of drawdowns. Recent price action is mixed, with a very slight upward trend. Technical indicators are generally neutral to slightly positive. A short-term decline in relative divergence suggests some recent underperformance, but the MRI indicates low market risk, and the hybrid signal recommends a buy. The expected return is very high, but past performance is not indicative of future results, especially given XRP-USD's volatile history. The news items are not especially helpful.

**Disclaimer:** *This analysis is based solely on the data provided and does not constitute financial advice. Investment decisions should be made after consulting with a qualified financial advisor and conducting thorough due diligence.*
